• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Drug-Device Combinations

Sequel twiist developer DEKA acquires assets, IP from Diatech Diabetes

October 7, 2025 By Sean Whooley

Diatech Diabetes Logo

Diatech Diabetes announced today that DEKA Research & Development acquired its core assets and intellectual property (IP). DEKA, the firm behind the Sequel Med Tech twiist automated insulin delivery system, developed the underlying drug delivery technology for the recently launched pump. Dean Kamen, co-founder of Sequel and founder of DEKA, commercialized the first wearable insulin […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Mergers & Acquisitions, Technology Tagged With: Deka Research and Development, Diatech Diabetes

Ashley McEvoy explains how Insulet is using AI to advance diabetes care

October 7, 2025 By Sean Whooley

Ashley McEvoy Insulet President and CEO

While Ashley McEvoy has only been at the helm of Insulet (Nasdaq:PODD) for five months, she’s already seeing the increasing role of AI in the company’s technology. Speaking during a “CEOs Unplugged” session covering the emergence of AI in medical technology at AdvaMed’s The MedTech Conference in San Diego alongside Stryker CEO Kevin Lobo and […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: Insulet

Senseonics posts strong preliminary Q3 sales, reverse stock split

October 6, 2025 By Sean Whooley

Senseonics logo

Senseonics (NYSE:SENS) today announced preliminary revenues for the third quarter and plans to conduct a reverse stock split. The Germantown, Maryland-based long-term implantable continuous glucose monitor maker expects approximately $8.1 million in revenue for the third quarter of 2025. That marks a 91% uptick from the third quarter of 2024. The company attributed its growth […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Implants, MassDevice Earnings Roundup, Patient Monitoring, Wall Street Beat Tagged With: Senseonics

Modular Medical appoints new head of international operations as insulin patch pump advances

October 6, 2025 By Sean Whooley

Modular Medical Head of International Operations David Bosshard LinkedIn

Modular Medical (Nasdaq:MODD) announced today that it appointed David Bosshard as its new head of international operations. Bosshard joins the company as it looks to advance its insulin delivery technology. San Diego-based Modular Medical develops pump technology designed for “almost-pumpers.” It targets adults with a user-friendly, affordable design. Modular Medical’s current pump, the MODD1, won […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Personnel, Technology Tagged With: modularmedical, Personnel Moves

Court sides with Medtronic in insulin pump class action suit

October 2, 2025 By Sean Whooley

Medtronic World Diabetes Day

A Minnesota judge has dismissed a class action lawsuit alleging securities fraud related to insulin pumps made by Medtronic (NYSE:MDT). Laura M. Provinzino, U.S. District Judge for the District of Minnesota, granted Medtronic’s motion to dismiss the suit initially brought forward by investors in 2022. Provinzino’s dismissal comes about a year-and-a-half after Katherine M. Menendez, […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Legal News, Technology Tagged With: Medtronic, minimed

ClearPoint Neuro is developing a robotic neuro-navigation system for drug delivery

October 2, 2025 By Sean Whooley

Clearpoint Neuro logo (1)

ClearPoint Neuro (Nasdaq:CLPT) announced today that it is developing a proprietary robotic neuro-navigation system. The Solana Beach, California-based company says its new product category can enable its navigation software to operate the Kuka LBR robotic arm, supporting all minimally invasive cranial surgical procedures. Those include cell and gene therapy infusions, laser catheter placement, biopsy workflows […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Neurological, Pharmaceuticals, Research & Development, Surgical, Technology Tagged With: ClearPoint Neuro

Convatec to invest $1B in R&D including $600M in U.S.

October 1, 2025 By Sean Whooley

ConvaTec

Convatec announced today that it plans to invest more than $1 billion over the next decade to accelerate its R&D efforts around the world. The global, multi-year planned investment includes $600 million going into the U.S. over the next 10 years. London-based Convatec said its planned investment marks a significant milestone in its mission, underlining […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Research & Development Tagged With: Convatec

Elutia closes $88M bioenvelope sale to Boston Scientific

October 1, 2025 By Sean Whooley

Elutia EluPro drug-eluting bioenvelope (1)

Elutia (Nasdaq:ELUT) announced today that it closed the $88 million sale of its bioenvolope technologies to Boston Scientific. Last month, the Gaithersburg, Maryland-based company announced an agreement to sell its EluPro and CanGaroo drug-eluting bioenvelopes to Boston Scientific in an all-cash deal. It designed these technologies to protect patients receiving implantable medical devices. With the […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Implants, Mergers & Acquisitions Tagged With: Boston Scientific, Elutia

Tandem t:slim X2 pump cleared for use with Lilly’s Lyumjev ultra-rapid insulin

September 29, 2025 By Sean Whooley

Tandem Diabetes Care t_slim X2 with control IQ +

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received approval to deliver Lyumjev ultra-rapid acting insulin with its t:slim X2 pump. Eli Lilly offers the Lyumjev (insulin lispro-aabc injection) ultra-rapid acting insulin. Tandem can now provide its t:slim X2 pump with Control-IQ+ automated insulin delivery technology with the insulin in the U.S. This latest clearance […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Regulatory/Compliance, Technology Tagged With: Eli Lilly, Eli Lilly & Co., Tandem Diabetes Care

Sequel Med Tech, Arecor ink co-development agreement for ultra-rapid insulin with twiist

September 25, 2025 By Sean Whooley

sequel twiist automated insulin delivery AID system

Arecor Therapeutics announced today that it signed a co-development with Sequel Med Tech to pair their diabetes offerings. Cambridge, UK-based Arecor develops AT278 (500U/mL) ultra-rapid-acting insulin. The companies struck a deal to pair the insulin with the Sequel twiist automated insulin delivery system. Additionally, the deal includes a financing agreement with Ligand Pharmaceuticals to bring […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Research & Development, Technology Tagged With: Arecor Therapeutics, Sequel Med Tech

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 29
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • Interim pages omitted …
  • Page 374
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS